MHRA to Open 3rd Annual Allergies Summit This July with Keynotes from Stallergenes Greer, HAL Allergy and Nestle
Agenda released for SMi's 3rd annual allergies conference taking place on 6th and 7th July 2016 in Central London.
London, United Kingdom, March 29, 2016 --(PR.com)-- SMi Group are thrilled to announce the return of its 3rd annual Allergies conference taking place on 6th and 7th July in Central London.
Aimed at an audience of senior scientists and allergy specialists involved in immunology and drug research, Allergies 2016 will provide a platform to discuss pioneering clinical developments and the next generation of allergy therapeutics.
Created with a top panel of industry thought leaders, this year's event will capture expert insight by honing in on new pathways with novel vaccines and adjuvants, immunoassays for molecular diagnostic’s, paediatric allergies, personalised treatments and allergen specific immunotherapies. Through strategic direction and regulatory guidance, the programme will look to strengthen knowledge in topics such as biomarker validation and arm attendees with the key requirements and tools for successful drug trials and study outcomes.
Highlights include an opening keynote address from Dr Carl Dolman, Immunoglobulins and Allergen Study Director at The National Institute for Biological Standards and Control (NIBSC), MHRA. Entitled: Standardisation of Biologics Material, the address will provide a progressive outlook into future developments and insight into the NIBSC portfolio.
Other notable speakers on the panel include:
Dr Thierry Batard, Senior Dir. Innovation & Technological Platforms, Stallergenes Greer
Dr Dirk-Jan Opstelten, R&D Director, HAL Allergy
Prof Tim Higenbottam, R&D Director, Allergy Therapeutics Ltd
Prof Kimihiro Okubo, Department of Otorhinolaryngology, Nippon Medical School
Karen Knipping, Senior Scientist, Danone Nutricia Research
Dr Sophie Nutten, Group Leader of the Allergy Group, Nestle Research Centre
Dr Anne Marie Salapatek, President & Chief Scientific Officer, Inflamax Research Inc
For those who are interested in attending, there is currently a £400 early bird saving available online.
A brochure and a full line-up of speakers is available at www.allergies-event.com
Allergies 2016
Conference: 06 - 07 July 2016 | Interactive Workshop: 05 July 2016
Holiday Inn Kensington Forum, London UK
www.allergies-event.com
Sponsored by DBV Technologies, Indoor Biotechnologies and Inflamax
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defense, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the worlds most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk.
Aimed at an audience of senior scientists and allergy specialists involved in immunology and drug research, Allergies 2016 will provide a platform to discuss pioneering clinical developments and the next generation of allergy therapeutics.
Created with a top panel of industry thought leaders, this year's event will capture expert insight by honing in on new pathways with novel vaccines and adjuvants, immunoassays for molecular diagnostic’s, paediatric allergies, personalised treatments and allergen specific immunotherapies. Through strategic direction and regulatory guidance, the programme will look to strengthen knowledge in topics such as biomarker validation and arm attendees with the key requirements and tools for successful drug trials and study outcomes.
Highlights include an opening keynote address from Dr Carl Dolman, Immunoglobulins and Allergen Study Director at The National Institute for Biological Standards and Control (NIBSC), MHRA. Entitled: Standardisation of Biologics Material, the address will provide a progressive outlook into future developments and insight into the NIBSC portfolio.
Other notable speakers on the panel include:
Dr Thierry Batard, Senior Dir. Innovation & Technological Platforms, Stallergenes Greer
Dr Dirk-Jan Opstelten, R&D Director, HAL Allergy
Prof Tim Higenbottam, R&D Director, Allergy Therapeutics Ltd
Prof Kimihiro Okubo, Department of Otorhinolaryngology, Nippon Medical School
Karen Knipping, Senior Scientist, Danone Nutricia Research
Dr Sophie Nutten, Group Leader of the Allergy Group, Nestle Research Centre
Dr Anne Marie Salapatek, President & Chief Scientific Officer, Inflamax Research Inc
For those who are interested in attending, there is currently a £400 early bird saving available online.
A brochure and a full line-up of speakers is available at www.allergies-event.com
Allergies 2016
Conference: 06 - 07 July 2016 | Interactive Workshop: 05 July 2016
Holiday Inn Kensington Forum, London UK
www.allergies-event.com
Sponsored by DBV Technologies, Indoor Biotechnologies and Inflamax
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defense, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the worlds most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk.
Contact
SMi Group
Teri Arri
+44 (0) 207 827 6162
http://www.pain-therapeutics.co.uk/prcom
Teri Arri
+44 (0) 207 827 6162
http://www.pain-therapeutics.co.uk/prcom
Contact
Categories